Etanercept in graft-versus-host disease

被引：24

作者：

Andolina, M ^{[1
]}

Rabusin, M ^{[1
]}

Maximova, N ^{[1
]}

Di Leo, G ^{[1
]}

机构：

[1] Inst Maternal & Child Hlth, Bone Marrow Unit, Trieste, Italy

来源：

BONE MARROW TRANSPLANTATION | 2000年 / 26卷 / 08期

关键词：

D O I：

10.1038/sj.bmt.1702638

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

引用

收藏

页码：929 / 929

页数：1

相关论文

共 6 条

[1] Tumor necrosis factor inhibitor ameliorates murine intestinal graft-versus-host disease
Brown, GR
Lindberg, G
Meddings, J
Silva, M
Beutler, B
Thiele, D
[J]. GASTROENTEROLOGY, 1999, 116 (03) : 593 - 601
[2] Differential effects of anti-Fas ligand and anti-tumor necrosis factor α antibodies on acute graft-versus-host disease pathologies
Hattori, K
Hirano, T
Miyajima, H
Yamakawa, N
Tateno, M
Oshimi, K
Kayagaki, N
Yagita, H
Okumura, K
[J]. BLOOD, 1998, 91 (11) : 4051 - 4055
[3] Etanercept in children with polyarticular juvenile rheumatoid arthritis.
Lovell, DJ
Giannini, EH
Reiff, A
Cawkwell, GD
Silverman, ED
Nocton, JJ
Stein, LD
Gedalia, A
Ilowite, NT
Wallace, CA
Whitmore, J
Finck, BK
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (11) : 763 - 769
[4] MOHLER KM, 1993, J IMMUNOL, V151, P1548
[5] TUMOR-NECROSIS-FACTOR CACHECTIN IS AN EFFECTOR OF SKIN AND GUT LESIONS OF THE ACUTE PHASE OF GRAFT-VS-HOST DISEASE
PIGUET, PF
GRAU, GE
ALLET, B
VASSALLI, P
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 166 (05) : 1280 - 1289
[6] GRAFT-VERSUS-HOST DISEASE - NEW DIRECTIONS FOR A PERSISTENT PROBLEM
VOGELSANG, GB
HESS, AD
[J]. BLOOD, 1994, 84 (07) : 2061 - 2067